Skip Navigation


BJA Advance Access originally published online on May 14, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
93/1/21    most recent
aeh150v1
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Zaugg, M.
Right arrow Articles by Foëx, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zaugg, M.
Right arrow Articles by Foëx, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 2004, Vol. 93, No. 1 21-33
© 2004 The Board of Management and Trustees of the British Journal of Anaesthesia

Myocardial injury and its prevention in the perioperative setting

M. Zaugg*,1,2, M. C. Schaub2 and P. Foëx3

1 Institute of Anaesthesiology, University Hospital Zürich, Switzerland. 2 Institute of Pharmacology and Toxicology, University of Zürich, Switzerland. 3 Nuffield Department of Anaesthetics, The John Radcliffe Hospital, Oxford, UK

*Corresponding author: Institute of Anaesthesiology, University Hospital Zürich, Rämistrasse 100, CH-8091 Zürich, Switzerland. E-mail: michael.zaugg@usz.ch

Keywords: anaesthetic techniques, inhalation; complications, myocardial ischaemia; heart, cardioprotection; hibernation; stunning

The first 150 words of the full text of this article appear below.

In the UK, there are ~20 000 deaths within 30 days of surgery every year, 9000 of which have a cardiac cause.93 The number of major cardiac complications is likely to be in the region of 150 000 per annum. As 60% of patients who die within 30 days of surgery suffer from coronary artery disease94 it is reasonable to assume that the majority of cardiac complications of anaesthesia and surgery results from myocardial ischaemia leading to myocardial injury (Fig. 1).


Figure Removed (Available Only in the Full Text)
View larger version (49K):
[in this window]
[in a new window]
 
Fig 1 Schematic characterization of cardiac ‘stunning’ and ‘hibernation’. In stunning normal blood flow and energy metabolism are accompanied by reduced contractility, designated as ‘flow-contractility mismatch’. The impaired contractile function seems to be caused primarily by increased intracellular Ca2+, activation of Ca2+-dependent non-lysosomal cysteine proteinases (calpains), and degradation of sarcomere-associated proteins including troponin-I. Hibernation is characterized by reduced contractility accompanied by reduced oxygen consumption as a . . . [Full Text of this Article]

 
Myocardial responses to ischaemia

Acute myocardial ischaemia
Mechanisms of myocardial ischaemia
Myocardial stunning (flow-contractility mismatch)
Mechanisms of myocardial stunning
Myocardial hibernation
Mechanisms of myocardial hibernation
Myocardial preconditioning
Mechanisms of myocardial preconditioning
Role of adenosine
Role of bradykinin
Role of opioids
Role of adrenergic receptors
Role of free oxygen radicals and nitric oxide
Calcium ions
Protein kinase C (PKC)
Role of ATP-dependent potassium channels (KATP channels)
Other beneficial effects associated with cardiac preconditioning
Late preconditioning
Remote preconditioning
Protective effects of anaesthetics against ischaemia

Anaesthetics and myocardial stunning
Anaesthetics and cardiac preconditioning
Isoflurane
Sevoflurane
Desflurane
Pharmacological interventions by nonanaesthetic agents currently used for the prevention of perioperative ischaemia
Nitroglycerin
Calcium channel blockers
Adenosine modulators
{alpha}2-Adrenoceptor agonists
Nicorandil
Statins
ß-Blockers
Conclusions

Acknowledgements


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Br J AnaesthHome page
M. Carles, J. Dellamonica, J. Roux, D. Lena, J. Levraut, J. F. Pittet, P. Boileau, and M. Raucoules-Aime
Sevoflurane but not propofol increases interstitial glycolysis metabolites availability during tourniquet-induced ischaemia reperfusion
Br. J. Anaesth., January 1, 2008; 100(1): 29 - 35.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Zhu, P. A. Hofmann, and J. K. Buolamwini
Cardioprotective effects of novel tetrahydroisoquinoline analogs of nitrobenzylmercaptopurine riboside in an isolated perfused rat heart model of acute myocardial infarction
Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2921 - H2926.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Raphael, S. Abedat, J. Rivo, K. Meir, R. Beeri, T. Pugatsch, Z. Zuo, and Y. Gozal
Volatile Anesthetic Preconditioning Attenuates Myocardial Apoptosis in Rabbits after Regional Ischemia and Reperfusion via Akt Signaling and Modulation of Bcl-2 Family Proteins
J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 186 - 194.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
J. G. Bovill
Intravenous Anesthesia for the Patient with Left Ventricular Dysfunction
Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2006; 10(1): 43 - 48.
[Abstract] [PDF]


Home page
Br J AnaesthHome page
I. Malagon, K. Hogenbirk, J. van Pelt, M. G. Hazekamp, and J. G. Bovill
Effect of three different anaesthetic agents on the postoperative production of cardiac troponin T in paediatric cardiac surgery
Br. J. Anaesth., June 1, 2005; 94(6): 805 - 809.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
S.J. Howell, J.W. Sear, and J.D. Young
Editorial: Cardiovascular medicine and Moore's Law
Br. J. Anaesth., July 1, 2004; 93(1): 1 - 2.
[Full Text] [PDF]